Wells Pharma Recalls Fentanyl Injectable Solution
Wells Pharma of Houston LLC is recalling Fentanyl Citrate Injectable Solution, a Schedule II narcotic. The recall is classified as Class II and is currently ongoing. The recall is due to potential contamination concerns.
Topics
Developing
- 900d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 900d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 900d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 900d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
OpenFDA
“FDA Drug Recall: Wells Pharma of Houston LLC | Class Class II | Status: Ongoing | Product: fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per mL), 25 mL, wells pha | Reason...”
CBN São Paulo
“do Esgolero Bruno, que tem as informações ao material e o material.”
OpenFDA
“1250 mcg/25mL (50 mcg per mL), 25 mL, wells pha | Reason...”
2m ago
“Wells Pharma Recalls Fentanyl Injectable Solution”
1010 WINS NYC
“little culinary wager, Frank Gala-Veri, a descendant of the brothers credited with...”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade